Ethereum (ETH) founder Vitalik Buterin transferred 1,009 ETH from one wallet to another, sparking concerns about a potential sell-off.Ethereum (ETH) founder Vitalik Buterin transferred 1,009 ETH from one wallet to another, sparking concerns about a potential sell-off.

Vitalik Buterin Moves 1,009 Ethereum, Sparks Sell-Off Concerns

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
Vitalik Buterin Moves 1,009 Ethereum, Sparks Sell-Off Concerns

Ethereum (ETH) founder Vitalik Buterin transferred 1,009 ETH from one wallet to another, sparking concerns about a potential sell-off. The transaction, valued at approximately $2.94 million, has attracted significant attention from traders. On-chain tracking platform Lookonchain reported the movement, which many are closely monitoring for signs of market shifts.

All Eyes on Ethereum’s On-Chain Movements

Buterin’s move involved shifting the Ethereum from his personal wallet to a different one. Historically, transfers like this often raise questions about potential sales, especially when linked to founder wallets. However, there was no evidence suggesting Buterin sent the ETH to an exchange for sale.

Despite no immediate signs of a sale, market speculation persists. Traders are still cautious, watching for any further Ethereum movements from Buterin. Analysts remain unsure whether the transfer indicates a portfolio rearrangement or an impending sale.

Some experts argue that Buterin may simply be preparing for future investments or diversifications. Others suggest he may be setting aside assets for possible liquidity needs. While the exact reason remains unclear, market participants continue to monitor the situation closely.

Market Concerns Following Ethereum’s Performance

Ethereum’s price has been volatile lately. The cryptocurrency recently traded at $2,912.38, showing a slight 0.6% increase within 24 hours. Ethereum’s price reached an intraday high of $2,981.31, but it faced rejection at the $3,000 mark.

The downturn came as Ethereum trading volume dropped by over 21%, falling to $21.8 billion. This reduction in trading activity has added to bearish sentiment surrounding Ethereum. Despite the recent uptick, Ethereum has lost 5.71% over the past week and around 30% in the last month.

While Ethereum faces short-term challenges, it remains above $2,900, signaling potential for a rebound. Market participants remain divided on the future direction of the coin. Many are awaiting further on-chain data to gauge Ethereum’s true market position.

Ethereum’s Outlook Remains Mixed Amid Larger Market Trends

In other news, institutional investors, like BlackRock, have been adjusting their Ethereum holdings. BlackRock moved 36,283 ETH into Coinbase (NASDAQ: COIN) Prime on November 24, adding fuel to concerns over large-scale sell-offs. These actions, though concerning, have not yet shown immediate impacts on Ethereum’s price.

Some market watchers remain optimistic about Ethereum’s long-term prospects. Despite recent sell-offs, Ethereum’s future still shows promise for growth. Whether the cryptocurrency can regain its bullish momentum depends on broader market trends and on-chain movements.

This article was originally published as Vitalik Buterin Moves 1,009 Ethereum, Sparks Sell-Off Concerns on Crypto Breaking News – your trusted source for crypto news, Bitcoin news, and blockchain updates.

Market Opportunity
Ethereum Logo
Ethereum Price(ETH)
$2,044.13
$2,044.13$2,044.13
-1.87%
USD
Ethereum (ETH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Supported by hike speculation and PMIs – Danske Bank

Supported by hike speculation and PMIs – Danske Bank

The post Supported by hike speculation and PMIs – Danske Bank appeared on BitcoinEthereumNews.com. Danske Research Team points out that the Euro was the second-
Share
BitcoinEthereumNews2026/03/23 15:59
The geopolitics of anti-corruption as global advisory firms face debarment in the Horn of Africa

The geopolitics of anti-corruption as global advisory firms face debarment in the Horn of Africa

The World Bank’s debarment of PwC and EY for fraud in Ethiopia and Somalia has lifted the veil on the fragility of the Western development model, creating a strategic
Share
Theexchange2026/03/23 16:33
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11